Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients
NCT ID: NCT03385031
Last Updated: 2019-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2018-01-01
2018-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer
NCT03863301
Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer
NCT02316561
Radiotherapy After Primary Chemotherapy for Breastcancer
NCT01279304
Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NCT05350722
Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment.
NCT03375801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1
whole breast irradiation, CBCT imaging at first and last fraction of radiotherapy treatment
CBCT imaging
CBCT imaging at first and last fraction of radiotherapy treatment
group 2
simultaneous integrated boost, CBCT imaging at first and last fraction of radiotherapy treatment
CBCT imaging
CBCT imaging at first and last fraction of radiotherapy treatment
group 3
patients with seroma at start radiation treatment (whole breast irradiation or simultaneous integrated boost), CBCT imaging at first and last fraction of radiotherapy treatment
CBCT imaging
CBCT imaging at first and last fraction of radiotherapy treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBCT imaging
CBCT imaging at first and last fraction of radiotherapy treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned for external beam radiation treatment.
* Whole breast irradiation or Simultaneous integrated boost
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht Radiation Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karolien Verhoeven, PHD
Role: PRINCIPAL_INVESTIGATOR
Radiation Oncologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht Radiation Oncology
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zegers CML, Baeza JA, van Elmpt W, Murrer LHP, Verhoeven K, Boersma L, Verhaegen F, Nijsten SMJJG. Three-dimensional dose evaluation in breast cancer patients to define decision criteria for adaptive radiotherapy. Acta Oncol. 2017 Nov;56(11):1487-1494. doi: 10.1080/0284186X.2017.1349334. Epub 2017 Aug 29.
Related Links
Access external resources that provide additional context or updates about the study.
Three-dimensional dose evaluation in breast cancer patients to define decision criteria for adaptive radiotherapy.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P0268
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.